Company intelligence / Profile preview

Ostial Solutions

Campbell, California, United States

Ownership: Private
Development stage: Other

Overview

Ostial is a privately held medical technology company specializing in aorto-ostial interventions, particularly in cardiology and vascular surgery. Their flagship product, the FLASH™ Aorto-Ostial Angioplasty System, is a dual-balloon catheter designed to improve stent apposition and lesion coverage in both coronary and peripheral angioplasty. The system is commercially available in the U.S., with over 15,000 units sold across more than 300 hospitals, and has demonstrated a high rate of complete stent apposition (97% in clinical use) and low restenosis at 6 months[1][3].

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Ostial Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ostial Solutions.

Explore the full profile